Concourse Financial Group Securities, Inc. Equillium, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.64 - $1.13 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.66 - $2.33 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.73 - $3.0 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.48 - $0.74 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.72 - $0.9 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.72 - $0.9 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.49 - $0.79 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.56 - $1.24 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.83 - $2.26 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.93 - $3.14 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.69 - $3.26 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.99 - $4.19 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.77 - $6.99 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$4.84 - $6.91 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$5.11 - $7.64 $0 - $0
Q1 2021 May 13, 2021	BUY	$5.03 - $10.5 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$3.48 - $6.58 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$2.78 - $26.5 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$2.34 - $3.53 $0 - $0
Q1 2020 May 13, 2020	BUY	$2.3 - $5.5 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.0 - $5.0 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$3.31 - $5.6 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$5.28 - $8.2 $0 - $0
Q1 2019 May 15, 2019	BUY	$5.84 - $12.02 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$6.32 - $19.44 $0 - $0

Others Institutions Holding EQ

# of Institutions

Shares Held

11.5M

Call Options Held

38.1K

Put Options Held

Decheng Capital LLC Menlo Park, CA

4.45M
Shares

$3.34 Million
0.94% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.45M
Shares

$3.34 Million
1.82% of portfolio
Vanguard Group Inc Valley Forge, PA

842K
Shares

$631,461
0.0% of portfolio
Cota Capital Management, LLC San Francisco, CA

562K
Shares

$421,708
1.37% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

300K
Shares

$225,300
0.0% of portfolio

View Full List

About Equillium, Inc.

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $25.8M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

More about EQ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account